DocGo (DCGO) Competitors $2.12 -0.07 (-3.20%) Closing price 04:00 PM EasternExtended Trading$2.12 0.00 (-0.24%) As of 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. AVAH, PNTG, GRAL, FLGT, CSTL, AUNA, FTRE, TALK, SBC, and EHABShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Aveanna Healthcare (AVAH), The Pennant Group (PNTG), Grail (GRAL), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), Auna (AUNA), Fortrea (FTRE), Talkspace (TALK), SBC Medical Group (SBC), and Enhabit (EHAB). These companies are all part of the "healthcare" industry. DocGo vs. Aveanna Healthcare The Pennant Group Grail Fulgent Genetics Castle Biosciences Auna Fortrea Talkspace SBC Medical Group Enhabit DocGo (NASDAQ:DCGO) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Does the media prefer DCGO or AVAH? In the previous week, Aveanna Healthcare had 3 more articles in the media than DocGo. MarketBeat recorded 6 mentions for Aveanna Healthcare and 3 mentions for DocGo. DocGo's average media sentiment score of 1.33 beat Aveanna Healthcare's score of 0.00 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Is DCGO or AVAH more profitable? DocGo has a net margin of 4.35% compared to Aveanna Healthcare's net margin of -3.32%. DocGo's return on equity of 8.90% beat Aveanna Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% Aveanna Healthcare -3.32%N/A -0.89% Do analysts rate DCGO or AVAH? DocGo currently has a consensus price target of $4.89, indicating a potential upside of 128.05%. Aveanna Healthcare has a consensus price target of $5.00, indicating a potential upside of 11.11%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than Aveanna Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Aveanna Healthcare 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals & insiders believe in DCGO or AVAH? 56.4% of DocGo shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 2.7% of DocGo shares are owned by insiders. Comparatively, 7.8% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor DCGO or AVAH? DocGo received 23 more outperform votes than Aveanna Healthcare when rated by MarketBeat users. Likewise, 75.00% of users gave DocGo an outperform vote while only 36.76% of users gave Aveanna Healthcare an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4875.00% Underperform Votes1625.00% Aveanna HealthcareOutperform Votes2536.76% Underperform Votes4363.24% Which has better valuation & earnings, DCGO or AVAH? DocGo has higher earnings, but lower revenue than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$616.56M0.35$6.86M$0.1712.62Aveanna Healthcare$2.02B0.43-$134.52M-$0.07-64.29 Which has more volatility and risk, DCGO or AVAH? DocGo has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500. SummaryDocGo beats Aveanna Healthcare on 12 of the 18 factors compared between the two stocks. Remove Ads Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$216.20M$875.02M$5.29B$7.35BDividend YieldN/A2.62%5.11%4.31%P/E Ratio7.5749.7121.7117.77Price / Sales0.357.23379.1097.68Price / Cash23.6226.1438.1534.64Price / Book0.724.226.433.98Net Income$6.86M-$5.50M$3.21B$247.44M7 Day Performance-15.20%3.77%5.23%4.44%1 Month Performance-25.87%0.97%-9.53%-7.73%1 Year Performance-36.90%77.25%10.95%1.28% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo3.1167 of 5 stars$2.12-3.2%$4.89+130.7%-32.8%$216.20M$616.56M7.572,920News CoveragePositive NewsAVAHAveanna Healthcare0.9888 of 5 stars$4.71+4.9%$5.00+6.2%+100.0%$918.89M$2.02B-13.8533,000Gap DownPNTGThe Pennant Group3.289 of 5 stars$26.03+2.6%$34.80+33.7%+30.9%$903.81M$695.24M38.285,340News CoveragePositive NewsGRALGrail0.6585 of 5 stars$24.85+6.8%$20.00-19.5%N/A$842.29M$125.60M0.001,360Short Interest ↑News CoveragePositive NewsFLGTFulgent Genetics3.5259 of 5 stars$18.95-0.3%$16.00-15.6%-11.6%$584.91M$283.47M-3.431,010Positive NewsCSTLCastle Biosciences3.0164 of 5 stars$19.89+1.0%$38.75+94.8%+12.2%$573.61M$332.07M99.45540Positive NewsAUNAAuna3.6789 of 5 stars$7.21+6.8%$13.53+87.6%-8.8%$532.95M$4.39B18.9714,958Short Interest ↑Gap UpFTREFortrea3.7091 of 5 stars$5.36+3.5%$16.70+211.6%-86.4%$483.47M$2.70B-1.5718,000Short Interest ↓TALKTalkspace3.9405 of 5 stars$2.79+0.4%$4.50+61.3%-9.9%$469.94M$187.59M279.28500News CoveragePositive NewsSBCSBC Medical GroupN/A$4.19-0.2%N/AN/A$434.13M$205.42M0.00N/AEHABEnhabit2.0978 of 5 stars$7.77+0.1%$8.50+9.4%-24.8%$392.23M$1.03B-3.3510,800Positive News Remove Ads Related Companies and Tools Related Companies AVAH Alternatives PNTG Alternatives GRAL Alternatives FLGT Alternatives CSTL Alternatives AUNA Alternatives FTRE Alternatives TALK Alternatives SBC Alternatives EHAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.